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Abstract
Background
Antiretroviral therapy (ART) initiation in the community and outside of a traditional health
facility has the potential to improve linkage to ART, decongest health facilities, and minimize
structural barriers to attending HIV services among people living with HIV (PLWH). We conducted a systematic review and meta-analysis to determine the effect of offering ART initiation in the community on HIV treatment outcomes.
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Methods and findings
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We searched databases between 1 January 2013 and 22 February 2021 to identify randomized controlled trials (RCTs) and observational studies that compared offering ART initiation
in a community setting to offering ART initiation in a traditional health facility or alternative
community setting. We assessed risk of bias, reporting of implementation outcomes, and
real-world relevance and used Mantel–Haenszel methods to generate pooled risk ratios
(RRs) and risk differences (RDs) with 95% confidence intervals. We evaluated heterogeneity qualitatively and quantitatively and used GRADE to evaluate overall evidence certainty.
Searches yielded 4,035 records, resulting in 8 included studies—4 RCTs and 4 observational studies—conducted in Lesotho, South Africa, Nigeria, Uganda, Malawi, Tanzania,
and Haiti—a total of 11,196 PLWH. Five studies were conducted in general HIV populations,
2 in key populations, and 1 in adolescents. Community ART initiation strategies included
community-based HIV testing coupled with ART initiation at home or at community venues;
5 studies maintained ART refills in the community, and 4 provided refills at the health facility.
All studies were pragmatic, but in most cases provided additional resources. Few studies
reported on implementation outcomes. All studies showed higher ART uptake in community
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initiation arms compared to facility initiation and refill arms (standard of care) (RR 1.73, 95%
CI 1.22 to 2.45; RD 30%, 95% CI 10% to 50%; 5 studies). Retention (RR 1.43, 95% CI 1.32
to 1.54; RD 19%, 95% CI 11% to 28%; 4 studies) and viral suppression (RR 1.31, 95% CI
1.15 to 1.49; RD 15%, 95% CI 10% to 21%; 3 studies) at 12 months were also higher in the
community-based ART initiation arms. Improved uptake, retention, and viral suppression
with community ART initiation were seen across population subgroups—including men,
adolescents, and key populations. One study reported no difference in retention and viral
suppression at 2 years. There were limited data on adherence and mortality. Social harms
and adverse events appeared to be minimal and similar between community ART initiation
and standard of care. One study compared ART refill strategies following community ART
initiation (community versus facility refills) and found no difference in viral suppression (RD
−7%, 95% CI −19% to 6%) or retention at 12 months (RD −12%, 95% CI −23% to 0.3%).
This systematic review was limited by few studies for inclusion, poor-quality observational
data, and short-term outcomes.

Conclusions
Based on data from a limited set of studies, community ART initiation appears to result in
higher ART uptake, retention, and viral suppression at 1 year compared to facility-based
ART initiation. Implementation on a wider scale necessitates broader exploration of costs,
logistics, and acceptability by providers and PLWH to ensure that these effects are reproducible when delivered at scale, in different contexts, and over time.

Author summary
Why was this study done?
• Over the last decade HIV services have increasingly moved out of the health facility and
into the community through the provision of decentralized and differentiated HIV care.
• It remains unclear however whether initiating ART in a community setting will result in
treatment and safety outcomes that are comparable to facility-based ART initiation.

What did the researchers do and find?
• We conducted a systematic review to identify studies where ART was initiated at community locations, including homes, mobile vans, or other community venues.
• We identified 8 studies (including 11,196 HIV-positive people), 7 of which were conducted in sub-Saharan Africa; 4 were randomized controlled trials and 4 were cohort
studies.
• The methodological quality of the randomized controlled trials was high, but cohort
data were of poorer quality. Studies were generally pragmatic in design, but implementation outcomes were infrequently reported.
• Based on meta-analysis of this limited dataset, it appeared that ART initiation in the
community resulted in higher ART uptake, higher retention, and greater viral
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suppression at 1 year compared to facility-based ART initiation and refill, among HIVpositive people offered ART. These findings were consistent across population subgroups and various implementation strategies.
• There were insufficient data on serious adverse events or mortality to draw firm conclusions on these outcomes.

What do these findings mean?
• Community ART initiation may result in better outcomes than ART initiation in traditional health facilities.
• To increase the robustness of these findings, high-quality implementation research conducted in diverse settings, exploring optimum combinations of community ART initiation and ART refill strategies over longer time periods, will be critical.

Introduction
Initiating antiretroviral therapy (ART) in the community setting and outside of traditional
health facilities represents an innovative addition to “differentiated service delivery” models,
which seek to offer a greater range of options that meet a diversity of patient needs in the global
HIV service delivery enterprise. Community-based ART initiation has several potential benefits including reducing psychological and structural barriers that newly diagnosed HIV-positive people face in order to access a facility, as well as further decongesting crowded facilities
themselves. With a shift over the last decade to rapidly initiating ART in those who test HIVpositive, and decentralizing and differentiating follow-up after treatment initiation in the facility, community ART initiation represents the next step toward more patient-centered services
and may bridge the critical gap between testing and linkage to ART—a point in the HIV care
cascade when many disengage from care [1–3].
Despite this rationale, few studies have explored the effect of community ART initiation on
either short- or long-term outcomes. Community-based HIV testing, including mobile testing,
self-testing, testing campaigns, workplace testing, and index testing, frequently shows higher
coverage and uptake than traditional facility-based testing and has the ability to reach those
underserved by routine facility-based testing, particularly men and key populations [4,5].
Community-based medication refill for patients stable on ART, such as distribution directly to
patients’ homes or to community pick-up locations and pharmacies, has generally demonstrated success [6,7]. ART initiation, however, has traditionally been reserved for facilities
because of the perceived intensity of the encounter, but this assumption is not empirically supported. Qualitative data suggest that the act of going to a clinic is intimidating and confusing,
particularly in environments where stigma is present—making community ART initiation a
potentially important innovation [8].
A number of studies examining the effects of community ART initiation have been conducted, but synthesis and review are needed to appraise the quality of the data as well as assess
the top-line evidence of the effect of this approach on immediate and medium-term outcomes.
In addition, systematic reviews are required as a part of the guideline development processes
led by the HIV department at the World Health Organization (WHO), and therefore an
important step in the translation of evidence to practice. To explore the effect of initiating

PLOS Medicine | https://doi.org/10.1371/journal.pmed.1003646 May 28, 2021

3 / 22

PLOS MEDICINE

Community ART initiation: A systematic review

ART in a community setting on HIV treatment outcomes, we conducted a systematic review
that additionally characterized features of community ART initiation strategies to inform policy and implementation.

Methods
Search strategy and selection criteria
The protocol for this systematic review was registered on PROSPERO (CRD42019130272) and
followed PRISMA guidelines [9,10] (S1 Table). We searched the Cochrane Central Register of
Controlled Trials (CENTRAL, published in the Cochrane Library), MEDLINE (PubMed),
Embase (OVID), Africa-Wide Information and CINAHL (EBSCOhost), LILACS, and Web of
Science Core Collection from 1 January 2013 until 15 April 2019; this start date was based on
the 2013 WHO recommendation for decentralization of HIV treatment and care [11], and a
previous systematic review that searched for studies published from 1996 to 2013 and found
no published studies on community-based ART initiation prior to 2013 [12] (S1 Appendix).
Searches were updated on 1 April 2020 and again on 22 February 2021.
We included randomized and non-randomized study designs that enrolled HIV-positive
people of any age, conducted in low- and middle-income countries, and compared community
ART initiation to facility-based ART initiation or to another community-based ART initiation
strategy. We defined community ART initiation as initiation of ART outside of a traditional
health facility or workplace health center, by any cadre of health staff. Community settings
included, for example, mobile health services, community centers, and patients’ homes. ART
could be offered and initiated in the community and subsequently maintained in the community or at a health center. Our comparison arm was ART initiation in a traditional health facility; ART maintenance after initiation could occur within or outside of the health facility. No
language or age restrictions were applied to the search. We additionally searched HIV/AIDS
conferences including International AIDS Society (IAS) conferences and the Conference on
Retroviruses and Opportunistic Infections (CROI) until 10 March 2021, as well as the reference lists of included studies and relevant systematic reviews. We also searched ClinicalTrials.
gov and the WHO International Clinical Trials Registry Platform for ongoing studies.

Data extraction and methodological quality assessment
Abstract and full-text screening was done in duplicate, with discrepancies resolved by a third
author. Data from included studies were abstracted by a single author (SAA) and verified by a
second author (AAA). Data were extracted in a pre-piloted data extraction tool developed in
Airtable (https://airtable.com)—a commercially available web-based relational database tool.
We extracted key characteristics of each study, including (1) study location; (2) methods: study
design, dates and duration of study and follow-up, and number and type of sites; (3) study
population: number, age, sex, and inclusion/exclusion criteria; (4) intervention and comparator details; (5) outcomes: ART uptake, retention in care, viral suppression, mortality, adherence, and adverse events, extracted when possible with numerators, denominators, and/or
measures of association; and (6) indicators of risk of bias. Any discrepancies were resolved by
discussion among the authors. The Cochrane or Newcastle–Ottawa Scale tools were used to
assess risk of bias [13,14].

Assessment of study implementation characteristics
We additionally characterized studies according to PRECIS-2 criteria for how pragmatic or
explanatory included studies were—exploring eligibility assessments, recruitment procedures,
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settings, organizational characteristics, flexibility in intervention delivery and adherence, follow-up, primary outcome reporting, and primary analyses [15]. Although the tool is optimized
for randomized control trial (RCT) design, we applied PRECIS-2 concepts across all studies.
We also explored reporting of implementation outcomes in primary and additional study publications across 8 domains: acceptability, adoption, appropriateness, implementation cost, feasibility, fidelity, adaptation, penetration, and sustainability [16].

Data synthesis and statistical analysis
For pairwise meta-analyses, we used random effects generic inverse variance meta-analytic
models; we evaluated ART uptake (initiation) among all HIV-positive individuals, and for
retention in care and viral suppression we assessed these outcomes among all who initiated
ART. We determined risk ratios (RRs) and 95% confidence intervals for all outcomes and
additionally present risk differences (RDs) where absolute effects were deemed valuable for
interpretation. For cluster randomized trials we calculated the design effect using methods outlined in the Cochrane handbook (where dichotomous counts from each study are divided by
the quantity 1 + [M − 1] × ICC, where M is the average cluster size and ICC is the intra-cluster
correlation coefficient) to adjust estimates if we could not incorporate adjusted estimates
directly from study publications. We used Mantel–Haenszel methods to generate pooled estimates of binary data. We evaluated heterogeneity qualitatively through examining forest plots
and quantitatively through examination of the I2 statistic. Between-study variance was evaluated using the Paule–Mandel estimator for Tau2 and the associated I2 statistic [17]. We used
subgroup analyses to explore heterogeneity. For each outcome, we generated forest plots overall and subgrouped where relevant by study design, population type, and implementation features. We conducted tests for subgroup differences to determine if cohort and RCT data could
be pooled. R statistical software was used for all analyses [18].

Evidence appraisal
We evaluated the certainty/quality of the body of evidence contributing to the pooled effect
estimate for each outcome using criteria recommended by the GRADE Working Group,
including risk of bias, inconsistency, indirectness, imprecision, and other domains [19–22].

Results
Searches were conducted between 1 January 2013 and 22 February 2021 and yielded 4,035
abstracts for screening after deduplication. We identified 120 records for full-text screening
and 3 possibly eligible ongoing studies; 105 studies were excluded with reasons, and 15 publications representing 8 studies were included in the qualitative synthesis, with 7 studies
included in meta-analyses (Fig 1).
Four studies were RCTs, 2 individually randomized [23–25] and 2 cluster randomized
[26,27]; 3 were cohort studies with a comparison arm [28–30], and 1 study was a single-arm
cohort study [31]. Two studies were conducted in Nigeria [29,31] and Lesotho [23,27] each,
and 1 each was conducted in South Africa [25], Uganda [32], Malawi [26], Tanzania [28], and
Haiti [30]. Five studies were conducted in general populations, 2 included key population
groups, and 1 included adolescents (Table 1).
Studies incorporated several differentiated service delivery features including task shifting/
sharing and changes in the location and frequency of services (Table 2). Community ART initiation was in most cases delivered by a small team including a nurse and counselor or a village
health worker, but in some studies involved a larger team, including lab technicians, pharmacists, doctors, and additional community lay workers [28,29,31]. Within the community
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Fig 1. PRISMA flow diagram. CROI, Conference on Retroviruses and Opportunistic Infections; IAS, International AIDS Society; ICTRP, International Clinical
Trials Registry Platform.
https://doi.org/10.1371/journal.pmed.1003646.g001
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Table 1. General description of included studies.
Study

Study
Design

Country

Setting

Number of HIV
+ participants

Population type

Eligibility criteria for inclusion

Barnabas 2020
[24,25]

RCT

South Africa
and Uganda

Rural regions

1,315

General HIV
endemic
communities

ART naïve, WHO stage 1–3, CD4 cell
count > 100/μL, not pregnant or breastfeeding,
negative TB symptom screen, normal renal
function

Ibiloye 2018
[31]

Cohort
(single
arm)

Nigeria

Three districts in a
central state

935

Several key
populations: FSWs,
MSM, PWID

Any CD4 cell count

Labhardt 2018
[23,33,35]

RCT

Lesotho

Rural northern region

274

General HIV
endemic
communities

ART naïve, WHO stage 1–3, not pregnant or
breastfeeding, no chronic illness, CRAG
negative

Amstutz 2021
[27]

RCT
(cluster)

Lesotho

Rural northern region

257

General HIV
endemic community

ART naïve; weight > 35 kg; no other chronic
condition; physical, mental, and emotional
ability to participate; remaining in district for
HIV care

MacPherson
2014 [26]

RCT
(cluster)

Malawi

Blantyre (urban center)

768

General HIV
endemic
communities

CD4 cell count < 350/μL or WHO stage 3 or 4
or pregnant or breastfeeding

Oladele 2018
[29]�

Cohort

Nigeria

Fourteen donor-funded
6,270
high-HIV-burden
districts (urban and rural)

General HIV
endemic
communities

CD4 cell count < 500/μL or WHO stage 3 or 4

Reif 2017 [30]�� Cohort

Haiti

Port Au Prince (urban
center)

760

Adolescents and
young adults

Community care group: any CD4 count;
historical cohort: CD4 cell count < 350/μL

Tun 2019
[28,36]

Tanzania

High HIV prevalence
(major trucking routes)

617

FSWs

Any CD4 count

Cohort

CRAG, cryptococcal antigen screening; FSW, female sex worker; MSM, men who have sex with men; PWID, people who inject drugs; RCT, randomized controlled trial;
TB, tuberculosis.
�
Data restricted to patients testing for HIV in the community in the post-intervention period for intervention and control areas.
��

Unpublished data from conference abstract only.

https://doi.org/10.1371/journal.pmed.1003646.t001

setting, 2 studies initiated ART in the home, and the remaining studies initiated ART at community venues (such as mobile vans, individual homes, and other community venues). All
studies paired community ART initiation with community-based HIV testing strategies. Two
studies included HIV self-testing strategies; in one this was the primary method of HIV testing
[26], and in another HIV self-tests were distributed to those who declined testing and those
away from home in a subset of participants [27]. The location of ART refill collection (after
ART initiation) varied, with half of the studies having participants collect ART refills in the
community [28,30,31] and the other half having participants collect ART refills at the health
facility [23,26,29]; Once stabilized on ART, those receiving facility-based ART refills received
ART refills every 3 months. All studies initiated ART rapidly, either on the same day as testing
(5 studies) or within 7 days (3 studies). Six comparative studies compared community ART
initiation to facility-based ART initiation, with a similar subsequent frequency of ART refills
in all except 1 study [23], where refill frequency was monthly in the facility arm compared to
every 3 months in the community arm. One comparative study compared different ART refill
strategies across 2 community ART arms [27]. In several studies, community ART initiation
strategies were also combined with additional demand creation [26,31], enhanced support
strategies [28–30], or SMS reminders [27]—beyond what was offered in the facility-based initiation (standard of care) arm.
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Table 2. Intervention strategy details.
Study

Community ART group

Comparator
groups

Community
ART initiation
team

HIV testing ART initiation
site
site

Time
to
ART
start

Immediate
follow-up

Barnabas
2020 [24,25]

Nurse, lay
provider, ±
driver

Community

Mobile van

�7
days

Phone call at 7 Every 3
days, in
months
person at 1
month

Mobile van

Food parcels provided at Two comparisons:
each study visit, quarterly (1) facility ART
phone calls
initiation with
facility ART
maintenance, (2)
facility ART
initiation and
community ART
maintenance

Ibiloye 2018
[31]

Community
Community
facilitator, ART
clinician, nurse,
counselor,
pharmacist, lab
technician

Choice of
outreach
venues (CBO
offices, hotels/
guest houses)

Same
day

Not described

Outreach
venues in
community

STI care

No comparator

Labhardt
2018
[23,33,35]

Nurse,
counselor

Home

Home

Same
day

12–16 days
Every 3
and 6 weeks at months
health facility

Health
facility

Medical care at health
facility

Facility ART
initiation and
maintenance,
monthly clinic
visits

Amstutz
2021 [27]

Nurse,
counselor

Home

Home

Same
day

12–16 days at
VHW’s home

Every 3
months

VHW’s
home

Monthly ART reminder
via SMS, viral load result
triggered SMS

Home-based ART
initiation and
facility ART
follow-up and
maintenance

MacPherson
2014 [26]

Nurse,
counselor

Home (HIV
self-test)

Home

�7
days

2–4 weeks at
health facility

Every 3
months

Health
facility

Demand creation (HIV
self-test and home ART
awareness campaigns)

Facility ART
initiation and
maintenance

Oladele 2018
[29]

Doctor,
counselor,
pharmacist, lab
technician,
nurse,
community lay
workers

Community

Point of
identification
in community

Same
day

Phone calls/
SMS/home
visit every 3
days for 2
weeks, first
facility refill at
1 month

Every 3
months

Health
facility

Community mobilization Facility ART
campaigns, task sharing
initiation and
between providers and
maintenance
lay counselors

Reif 2017
[30,37]

Nurse, peer
educator

Facility and
community

Community
center

Same
day

At 1 month

Monthly

Community
center

Integrated clinical care,
FP, STI care, peer
support

Facility ART
initiation and
maintenance,
monthly clinic
visits, routine
facility-based
support groups

Tun 2019
[28,36]

Clinician,
Community
nurse, lab
technician, peer
educator

Mobile tent,
home

�7
days

Not described

Not
described

Mobile tent,
home

STI care, condom
distribution, FP, IPV
care, TB screening, CaCx
screening, escorted
referrals

Facility ART
initiation and
maintenance

ART refill ART refill
frequency location

Not
described

Additional support/
interventions beyond
routine care

CBO, community-based organization; CaCx, cervical cancer; FP, family planning; IPV, intimate partner violence; STI, sexually transmitted infection; TB, tuberculosis;
VHW, village health worker.
Macpherson 2014: 36% of those offered home ART in the home group chose facility ART initiation (64% selected home art initiation); Amstutz 2021: 6- and 12-month
ART refill visits were at health facility due to viral load measurement.
https://doi.org/10.1371/journal.pmed.1003646.t002
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Table 3. Risk of bias assessments.
Study

ART uptake/initiation among
HIV+ individuals

Retention in care among
ART initiators

Viral suppression among
ART initiators

Adherence among ART Mortality among HIV
initiators
+ individuals

Barnabas 2020

NA

NA

Low risk

NA

NA

Labhardt 2018

Low risk

Low risk

Low risk

NA

Some concerns

Amstutz 20211

NA

Some concerns

Some concerns

NA

Some concerns

MacPherson
2014

Low risk

Low risk

NA

High risk

Some concerns

Oladele 20182

Poor quality

NA

NA

NA

NA

3

Reif 2017

Poor quality

Poor quality

NA

NA

NA

Tun 20194

Poor quality

Poor quality

Poor quality

Poor quality

Poor quality

NA, not applicable.
Assessments based on Cochrane RoB 1 tool for randomized controlled trials (high risk, some concerns, low risk) or Newcastle–Ottawa Scale for cohort studies (poor
quality, good quality). Detailed assessments available in S2 Appendix.
1

Allocation concealment was not possible; recruiting teams were aware of household assignments prior to recruitment; participants were, however, unaware of
assignment during recruitment.

2

Comparison group (facility referral for ART initiation) very small compared to home ART group; fundamental differences between community and facility art

initiation groups (facility groups urban and with lower HIV prevalence); unadjusted numbers used in this analysis.
3
Overall risk of bias influenced by different sources of comparison (historical cohort with CD4 cell count < 350/μL) and intervention group; unadjusted estimates used
in analysis without controlling for any baseline characteristics; in addition, the comparative analysis remains unpublished.
4

Comparison group drawn from a different region; ascertainment of exposure not described; unadjusted estimates used in analysis; baseline imbalance in the group
characteristics; intervention group had substantially more newly diagnosed participants, which could affect uptake and retention.
https://doi.org/10.1371/journal.pmed.1003646.t003

Data from RCTs were generally judged as having high methodological quality (low risk of
bias), and observational data as having poor quality, as assessed by risk of bias tools (Table 3;
S2 Appendix). Observational studies had several methodological limitations, primarily related
to lack of comparability of study arms and inclusion of data that were not adjusted for baseline
imbalances in the pairwise meta-analysis.
We used PRECIS-2 criteria to assess how pragmatic or explanatory included studies were
(Tables 4 and S2): Overall, studies were highly pragmatic—conducted in real-world settings,
with flexible approaches to intervention delivery and few additional measures to ensure adherence to ART beyond what would occur in routine practice. RCTs were on average less pragmatic than cohort studies. Study procedures in trials that appeared less applicable in the “real
world” setting included the following: (1) more restrictive inclusion criteria that included, for
example, CD4 count measurement, or exclusion of those who were pregnant, breastfeeding, or
had chronic conditions [25,27,34]; (2) expertise and resources used to deliver the intervention,
with large, well-trained, multidisciplinary teams initiating ART in the community in some
studies [23,26], or the provision of food parcels at visits [25]; and (3) extensive patient followup, where tracing efforts appeared more rigorous than what may occur in routine practice [23]
—approaches that may not be entirely reproducible at scale.

ART initiation
Seven studies reported on ART initiation after offer of community ART; ART uptake among
those testing HIV-positive was high overall (85%), but there was substantial heterogeneity of
measurement time points, and uptake across studies ranged from 37% to 100% (Fig 2). The
lowest ART uptake (37%) was seen in a study where HIV self-testing was conducted and
paired with community ART initiation [26]. A single-arm study conducted in key populations
had an overall uptake of 77%, but this varied across key population subgroups, with uptake of
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Table 4. PRECIS-2 criteria/score.
Eligibility

Recruitment

Setting

Organization

Flexibility:
Delivery

Flexibility:
Adherence

Follow-up

Primary
outcome

Primary
analysis

Who is
selected to
participate in
the trial?

How are
participants
recruited into
the trial?

Where is
the trial
being
done?

What expertise
and resources are
needed to deliver
the intervention?

How should
the
intervention be
delivered?

What measures
are in place to
make sure
participants
adhere to the
intervention?

How closely
are
participants
followed up?

How relevant
is it to
participants?

To what
extent are
all data
included?

Barnabas
2020

4

4

5

3

4

5

5

5

5

Ibiloye 2018

5

4

5

3

5

5

3

5

5

Labhardt
2018

4

3

5

3

4

4

2

5

5

Amstutz
2021

5

4

5

3

4

5

4

5

5

MacPherson
2014

5

4

4

3

3

5

4

5

5

Oladele 2018

5

5

3

3

5

5

5

5

4

Reif 2017

5

5

4

4

5

5

4

5

4

Tun 2019

5

3

5

4

4

5

3

5

5

Study

Value of 5 (dark green) represents a very pragmatic approach and a value of 1 (yellow) represents a very explanatory approach. Detailed assessments presented in
S2 Table.
https://doi.org/10.1371/journal.pmed.1003646.t004

75% in female sex workers (FSWs), followed by men who have sex with men (68%) and people
who inject drugs (PWID) (53%); partners of key populations in this study had generally high
community ART uptake (93%) [31].
Five studies compared community ART initiation to facility-based ART initiation and refill
(standard of care). The meta-analysis of these studies showed higher ART initiation when

Fig 2. ART uptake in community ART initiation study arms, among HIV-positive and by outcome measurement time point. Tun 2019 was conducted in
female sex workers; Ibiloye 2018 included female sex workers, men who have sex with men, people who inject drugs, and partners of individuals in these key
populations.
https://doi.org/10.1371/journal.pmed.1003646.g002
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Fig 3. ART uptake: Community ART initiation versus standard of care among HIV-positive individuals, by study design. COM, community ART
initiation; e, number of events; n, number of participants; RCT, randomized controlled trial; RR, risk ratio; SOC, standard of care. MacPherson 2014
cluster-adjusted effect estimate based on the Cochrane method of adjusting for the design effect.
https://doi.org/10.1371/journal.pmed.1003646.g003

ART was offered in the community (Fig 3; RR 1.73, 95% CI 1.22 to 2.45; I2 98%), which translated to an absolute risk difference of 30% (95% CI 10% to 50%) (S1 Fig).
When subgrouped by study design, a stronger effect was seen in RCTs (RR 2.23, 95%
CI 1.21 to 4.11) as compared to cohort studies (RR 1.48, 95% CI 1.00 to 2.20); this difference accounted for some of the heterogeneity seen in the overall analysis but not all.
There was greater heterogeneity of effect estimates among cohort studies compared to
RCTs: 2 cohort studies, one conducted in FSWs (RR 1.41, 95% CI 1.27 to 1.57) and
another in adolescents (RR 1.08, 95% CI 1.05 to 1.12), showed smaller differences in ART
uptake compared to studies conducted in general HIV endemic communities (RR 2.20,
95% CI 1.56 to 3.12) (S2 Fig). Home ART initiation (explored only in RCTs) had comparable ART uptake (RR 2.23, 95% CI 1.21 to 4.11) to ART offered at other venues in the
community (RR 1.48, 95% CI 1.00 to 2.20) (S3 Fig). Same-day ART initiation (RR 1.91,
95% CI 1.05 to 3.46) showed similar ART uptake to initiation within 7 days (RR 1.45,
95% CI 1.30 to 1.62) (S4 Fig).

Retention in care
Four studies compared retention in care between community ART initiation and facility ART
initiation and maintenance (standard of care) among HIV-positive individuals at 6–12 months
[23,26,28,30]. Retention was higher in the community ART initiation group compared to the
facility ART initiation group (RR 1.43, 95% CI 1.32 to 1.54), which translated to a risk difference of 19% (95% CI 11% to 28%) (Figs 4 and S5).
When compared to standard of care (facility-based ART initiation and refills), retention
did not appear to differ by population type, ART initiation site, refill site, or frequency of ART
refill (Fig 5). One study additionally reported retention among HIV-positive individuals at 24
months and found no difference between community ART initiation and facility ART initiation and maintenance (RD 5%, 95% CI −16% to 16%, p = 0.380) at this time point [33]. In
pooled analyses restricted to those who initiated ART, retention was no different between
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Fig 4. ART retention at 6–12 months among HIV-positive individuals. COM, community ART initiation; e, number of events; n, number of
participants; RCT, randomized controlled trial; RR, risk ratio; SOC, standard of care. MacPherson 2014 reflects cluster-adjusted numbers based
on the Cochrane method of adjusting for the design effect.
https://doi.org/10.1371/journal.pmed.1003646.g004

study arms (S6 Fig; RR 1.15, 95% CI 0.99 to 1.33). The single-arm study Ibiloye 2018 [31]
reported 73.2% retention in care among key populations of individuals who initiated ART in
the community ART arm after 7 months of follow-up.
An additional study that compared 2 community ART initiation arms reported slightly better retention at 12 months when community ART initiation was combined with facility refills
(71%) compared to community-based ART refills (60%); this however did not reach statistical
significance (RD −12%, 95% CI −23% to 0.3%) [27].

Viral suppression
Three studies compared viral suppression between community ART initiation and facility
ART initiation and maintenance (standard of care) arms among HIV-positive individuals at
12 months; this comparison showed better viral suppression in the community ART group
(RR 1.31, 95% CI 1.15 to 1.49) (Fig 6). One study additionally reported 24-month outcomes,
which showed no difference in viral load suppression in the community ART arm compared
to the facility ART arm (RD 3%, 95% CI −9% to 15%, p = 0.28) at this time point [33]. The
threshold for viral load suppression ranged from less than 100 copies/mL [23], to 1,000 copies/
mL [28]. In one study, viral suppression in the community ART arm was higher when data

Fig 5. ART retention at 6–12 months among HIV-positive individuals, by implementation strategy. COM, community ART
initiation; FSW, female sex workers; ND, not determined; RR, risk ratio; SOC, standard of care. MacPherson 2014 reflects clusteradjusted numbers based on the Cochrane method of adjusting for the design effect.
https://doi.org/10.1371/journal.pmed.1003646.g005
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Fig 6. Viral suppression among HIV-positive individuals at 12 months: Community ART initiation versus facility-based care. COM,
community ART initiation; e, number of events; n, number of participants; RCT, randomized controlled trial; RR, risk ratio; SOC, standard of
care.
https://doi.org/10.1371/journal.pmed.1003646.g006

were restricted to men from a South African subgroup (RR 1.39, 95% CI 1.17 to 1.66) [25].
Meta-analysis of viral suppression restricted to those who initiated ART showed no difference
in viral suppression between treatment arms at 12 months (RR 1.05, 95% CI 0.86 to 1.29) (S7
Fig).
Two studies compared community ART initiation with hybrid community–facility ART
strategies, including either facility-based ART initiation or facility-based ART refill (Table 5).
One compared community ART initiation and refills versus facility ART initiation with community ART refills [24,25] and found no difference in viral suppression between these 2 strategies. When analysis was restricted to the South African male subgroup, community ART
initiation and maintenance appeared to have better viral suppression than if ART was initiated
at the facility and maintained in the community (RR 1.26, 95% CI 1.04 to 1.51) in this study.
Another study compared 2 community ART initiation strategies, one with ART refills delivered in the community versus another with refills collected at the health facility; this comparison showed no difference in viral suppression at 12 months between refill strategy arms (RD
−7%, 95% CI −20% to 6%) [27].

ART adherence
There was no difference in ART adherence among ART initiators at 6 months in the 2 studies
contributing to this comparative analysis (RR 0.92, 95% CI 0.84 to 1.02) (Fig 7). Adherence
was assessed as not missing a single dose in the past 4 days [26] or not missing a dose in the
past 7 days as assessed by self-report [28].
Table 5. Viral suppression among HIV-positive individuals at 12 months: Community ART initiation and refill versus community–facility hybrid initiation and
refill strategies.
Study

Community ART

Hybrid community–facility ART

Effect estimate, 95% CI

ART initiation

ART refill site

ART initiation

ART refill site

Barnabas 2020

Community

Community

Facility

Community

RR 1.08, 95% CI 0.98 to 1.19

Amstutz 2021

Community

Community

Community

Facility

RD −7%, 95% CI −20% to 6%

RD, risk difference; RR, risk ratio.
https://doi.org/10.1371/journal.pmed.1003646.t005
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Fig 7. ART adherence among ART initiators at 6 months. COM, community ART initiation; e, number of events; n, number of
participants; RR, risk ratio; SOC, standard of care. MacPherson 2014 reflects cluster-adjusted estimates based on the Cochrane method of
adjusting for the design effect.
https://doi.org/10.1371/journal.pmed.1003646.g007

Mortality
Overall, there were few events contributing to this outcome. Three studies contributed to the
comparative analysis of mortality (at 6 to 12 months), showing no difference in mortality
among those who initiated ART in the community compared with those who initiated in the
health facility (Fig 8; RR 2.37, 95% CI 0.56 to 10.05). The Ibiloye 2018 study reported overall
mortality in its community ART non-comparative cohort study at 3, 6, and 9 months on ART
as 3.4%, 3.7%, and 3.9%, respectively. Additionally, Amstutz et al. reported 5% (6/118) mortality in the community ART initiation and refill arm, compared to 0% (0/139) mortality in the
hybrid community ART initiation and facility refill arm [27].

Adverse events and social harms
There was variable adverse event reporting, including mild, serious, and severe adverse events,
social harms, and opportunistic infection incidence (Table 6). Severe adverse events in community ART initiation arms ranged from 1% to 6% and in facility ART initiation arms ranged
from 1% to 2% [23,25,30,33]. There were very few opportunistic infections or social harms;
this was however infrequently reported in the included studies.

Certainty of review findings (GRADE assessment)
The certainty of the evidence (a combined assessment of strength of association, methodological quality, heterogeneity, and external validity) for the pooled (RCT and cohort) data on

Fig 8. Mortality among HIV-positive individuals at 12 months. COM, community ART initiation; e, number of events; n, number of participants; RCT,
randomized controlled trial; RR, risk ratio; SOC, standard of care.
https://doi.org/10.1371/journal.pmed.1003646.g008
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Table 6. Adverse events among HIV-positive.
Study

Adverse events

Opportunistic infections

Social harms

Community ART Facility ART
initiation
initiation

Community ART
initiation

Facility ART
initiation

2 (1%) TB
cases

—

—

—

—

0—increased stigma or 0—increased stigma
unintended disclosure or unintended
disclosure

8 (2%) severe and 2
(0.4%) serious
adverse events

—

—

2 events

0 events

—

5 (1%) severe and 4
(1%) serious adverse
events

—

—

—

0 events

Amstutz
2021 (a)

7 (6%) events—serious adverse events

—

—

—

—

—

Amstutz
2021 (b)

7 (3%) events—serious adverse events

—

—

—

—

—

Community ART initiation

Facility ART
initiation

Labhardt
2018

6 (4%) events—2 rash, 1 nausea, 1
dizziness, 1 gynecomastia, 1 elevated
alanine aminotransferase level

2 events (1%)—2 rash 0 TB cases

Reif 2017

—

—

Barnabas
2020 (a)

7 (1%) severe and 7 (1%) serious adverse
events

Barnabas
2020 (b)

Barnabas 2020 (a): community ART initiation arm combined with community ART refills. Barnabas 2020 (b): community ART initiation arm combined with facility
ART refills. Amstutz 2021 (a): community ART initiation combined with community ART refills. Amstutz 2021 (b): community ART initiation combined with facility
ART refills.
https://doi.org/10.1371/journal.pmed.1003646.t006

primary outcomes of uptake, retention, and viral suppression among HIV-positive individuals
was graded as low to moderate (Table 7); effect estimates were downgraded due to high risk of
bias in the contributing observational studies (Table 7). Pooled estimates for adherence were
similarly graded as low certainty evidence, due to the inclusion of self-reported outcomes and
poor methodological quality. Very few events contributed to the mortality analysis, resulting
in very low certainty evidence for this outcome.

Implementation outcomes
Few studies reported on implementation outcomes of community ART initiation, 2 studies
reported on cost, and no studies reported on acceptability, penetration, adoption, fidelity,
adaptations, feasibility, or sustainability related to community ART initiation.
Of the 2 studies reporting on costs, one reported on the community ART initiation arm
only [26], and the second reported cost comparisons of facility ART initiation and community
ART initiation across 3 study settings [25]. The Barnabas 2020 study demonstrated some variability across settings, with the cost per person virally suppressed higher with communitybased ART initiation compared to facility ART initiation in 2 of the settings (Table 8).

Ongoing studies
We identified 3 ongoing studies being conducted in Indonesia [38], Zimbabwe [39], and
Puerto Rico [40]. One study includes adolescents, and 2 studies include key population groups
(S3 Table).

Discussion
In this systematic review, we found that making ART initiation available in the community led
to increases in ART uptake, better retention, and improved viral suppression (over the course
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Table 7. Review evidence certainty assessment (GRADE): Community ART initiation versus facility ART initiation.
Certainty assessment
Number of
studies

Study design

Number of patients
Risk of
bias

Inconsistency Indirectness Imprecision Other Community ART Facility ART
initiation
initiation

Effect
Certainty
estimate (95%
CI)

ART initiation among PLWH
5

RCTs and
observational

Seriousa

Seriousb

Not serious

Not serious

None

4,621/6,466
(71.5%)

747/1,534
(48.7%)

RR 1.73
(1.22 to 2.45)

⊕⊕◯◯
LOW

2

RCTs

Not
serious

Seriousb

Not serious

Seriousc

None

315/503 (62.6%)

107/415
(25.8%)

RR 2.23
(1.21 to 4.11)

⊕⊕◯◯
LOW

3

Observational

Seriousa

Seriousb

Not serious

Not serious

None

4,306/6,148
(70.0%)

640/1,119
(57.2%)

RR 1.48
(1.00 to 2.20)

⊕◯◯◯
VERY LOW

Retention in care among PLWH at 6–12 months
4

RCTs and
observational

Seriousa

Not serious

Not serious

Not serious

None

513/716 (71.6%)

459/993
(46.2%)

RR 1.44
(1.33 to 1.56)

⊕⊕⊕◯
MODERATE

2

RCTs

Not
serious

Not serious

Not serious

Seriousc

None

216/627 (34.4%)

123/415
(29.6%)

RR 1.30
(1.07 to 1.58)

⊕⊕⊕◯
MODERATE

2

Observational

Seriousa

Not serious

Not serious

Not serious

None

297/359 (82.7%)

372/638
(58.3%)

RR 1.45
(1.33 to 1.59)

⊕⊕◯◯
LOW

Not serious

Very
seriousc

None

88/137 (64%)

81/137(59%)

RD 5%
(−16% to
16%)

⊕⊕⊕◯
LOW

Retention in care among PLWH at 24 months
1

RCT

Not
serious

Not serious

Viral suppression among PLWH at 12 months
3

RCTs and
observational

Seriousa

Not serious

Not serious

Not serious

None

590/873 (67.6%)

468/891
(52.5%)

RR 1.31
(1.15 to 1.49)

⊕⊕⊕◯
MODERATE

2

RCTs

Not
serious

Not serious

Not serious

Not serious

None

375/564 (66.5%)

316/583
(54.2%)

RR 1.26
(1.05 to 1.53)

⊕⊕⊕⊕
HIGH

1

Observational

Seriousa

Not serious

Not serious

Not serious

None

215/309 (69.6%)

152/308
(49.4%)

RR 1.41
(1.23 to 1.61)

⊕◯◯◯
VERY LOW

Not serious

Very
seriousc

None

78/137 (56.9%)

74/137
(54.0%)

RD 3%
(−9% to 15%)

⊕◯◯◯
VERY LOW

Not serious

Not serious

Seriousc

None

322/378 (85.2%)

184/212
(86.8%)

RR 0.92
(0.84 to 1.02)

⊕⊕◯◯
LOW

Not serious

Not serious

Very
seriousc

None

7/664 (1.1%)

1/572 (0.1%)

RR 2.37
⊕◯◯◯
(0.56 to 10.02) VERY LOW

Viral suppression among PLWH at 24 months
1

RCT

Not
serious

Not serious

Adherence among ART initiates at 6 months
2

RCTs and
observational

Seriousa

Mortality among PLWH at 6–12 months
3

RCTs and
observational

Seriousa

PLWH, people living with HIV; RCT, randomized cont rolled trial; RD, risk difference; RR, risk ratio.
a

Included observational studies that have methodological concerns—comparison groups drawn from different populations and baseline imbalances were not accounted
for in the analysis.

b 2

I statistic >90%

c

Few studies and events

https://doi.org/10.1371/journal.pmed.1003646.t007

of 1 year after ART offer), compared to traditional facility-based ART initiation. Models offering ART initiation in the community increased uptake by 30% and 1-year retention by 19%
compared to initiation and maintenance at a traditional health facility. This finding of higher
ART uptake in the community ART arm was consistent across study designs and various
implementation methods. In one head-to-head comparison of alternative ART refill distribution strategies after community ART initiation, 1-year retention and viral suppression was
comparable between community ART refill and facility refill. Another study measured 2-year
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Table 8. Cost analyses reported in included studies.
Community ART
initiation

Study

Currency

Total cost components

Cost measures reported Facility ART
initiation

MacPherson 2014
(Malawi)

2012 US
dollars

Community ART initiation (60.3%), staff training (0.6%),
community sensitization (0.5%), drugs (3%), consumables (13.8%),
equipment (8.1%), other recurrent items (13.7%); excludes HIV
testing costs

Average cost per
participant assessed

—

$97

Average cost per
participant initiated on
ART

—

$127

Cost of ART, trimethoprim-sulfamethoxazole, laboratory testing,
personnel, supplies, fuel, and overheads

Annual cost of
community-based ART
per client

$249

$312

Annual cost per person
virally suppressed

$422

$452

Annual cost of
community-based ART
per client

$249

$308

Annual cost per person
virally suppressed

$402

$380

Annual cost of
community-based ART
per client

$163

$217

Annual cost per person
virally suppressed

$214

$275

Barnabas 2020
(South Africaa)

Barnabas 2020
(South Africab)

Barnabas 2020
(Uganda)

2018 US
dollars

2018 US
dollars

2018 US
dollars

Cost of ART, trimethoprim-sulfamethoxazole, laboratory testing,
personnel, supplies, fuel, and overheads

Cost of ART, trimethoprim-sulfamethoxazole, laboratory testing,
personnel, supplies, fuel, and overheads

a

Midlands Kwazulu-Natal, South Africa.
Northern Kwazulu-Natal, South Africa.

b

https://doi.org/10.1371/journal.pmed.1003646.t008

outcomes and found viral suppression and retention to be no different at this time point
between those offered ART initiation in the community and those offered facility initiation.
There were too few events to confidently determine the effect of community ART initiation on
adherence and mortality. Similarly, few studies reported on adverse events or social harms.
These findings were based on the synthesis of 8 studies conducted primarily in low- and middle-income African countries with high to moderate HIV burden, representing diversity in
geographical locations and population groups in these settings.
The effect of community-based models for initiating ART had consistent effects across
implementation strategies and population subgroups. Community ART was provided through
a variety of distribution models: ART was provided at home, in mobile vans and tents, or at
community locations; ART was initiated by large multidisciplinary teams in some studies, and
in others was primarily nurse driven; and ART refills were subsequently distributed either in
the community or at health facilities. In comparative analyses, community ART initiation was
explored in general HIV endemic communities, men, adolescents, and FSWs, and in one
study was seen to be particularly beneficial for men—suggesting that this may be an additional
strategy for improving engagement in HIV services for men, who do not routinely attend
health services [8,41]. Among key populations, ART uptake was modest, with the lowest
uptake reported in PWID; however, comparative analyses also showed improved treatment
outcomes for these groups compared to facility-based offer of ART. Future studies focused on
population subgroups could help clarify which implementation strategies are most effective, in
which settings, and for whom.
Community ART initiation has the potential to expand differentiated service delivery models and move the entire HIV care cascade into the community, a service delivery approach that
both addresses structural barriers to attending health services for people living with HIV
(PLWH) and is highly relevant during the COVID-19 pandemic, when decongesting health
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services has become critical—widespread scale-up, however, needs careful consideration.
Although the studies in this review were relatively pragmatic in their design, implementation
by external partners, additional resources, technical and logistical assistance, and training provided by research teams may mean that more modest outcomes will be seen when these strategies are incorporated into large-scale public health programs with more limited resources [7].
Lessons can be learned from the implementation of community ART models for “stable” HIVpositive people, which demonstrated effectiveness in trials, but when brought to scale
highlighted some of the challenges of bringing services into the community, including difficulties with maintaining the ART supply chains, inadequate resources to support communitybased staff, patient concerns regarding HIV-related stigma in the community, and patient
preferences for facility-based care in some instances [42–45].
The mechanism by which offering ART in the community improves retention and viral
suppression appears to be through greater ART uptake and reduced loss to follow-up prior to
ART initiation. Once ART has been initiated, outcomes are similar to those of individuals who
initiate ART at a health facility. Analyses of the effect of offering ART to all PLWH on retention and viral suppression compared to analyses that were restricted to only those who initiated ART showed remarkably improved retention and viral suppression at 1 year in the
former compared to smaller differences between community and facility arms in the latter.
This suggests that expanding the number of PLWH who initiate ART by offering initiation in
the community could have a substantial impact on reaching ART coverage goals, if these
effects can be reproduced at scale [46].
Few studies included in this review assessed implementation outcomes beyond cost. Additional study findings regarding fidelity to intervention protocols, challenges and required
adaptations, explorations of variability in PLWH and provider preferences and acceptability,
provider and health system adoption, and sustainability could aid future implementation and
should be incorporated into future study design and reporting [47–50].
Our review findings were limited by there being few studies for inclusion, the incorporation
of observational data of poor methodological quality, and short-term HIV treatment outcome
measures. For systematic reviews evaluating implementation strategies, the inclusion of observational and programmatic data is critical; however, in order to generate robust and relevant
synthesized results, high-quality evidence is needed. Assessments of the methodological quality
of observational studies included in this review showed observational studies to be of low quality according to risk of bias tools; this was in large part due to the inclusion of data with
observed baseline imbalances in participant characteristics between intervention and comparison groups. Although some studies conducted analyses (e.g., interrupted time series) to adjust
for selection, these model outputs could not be included in meta-analyses, and therefore raw
unadjusted data were pooled with RCT data [29]. Results from observational studies were
however consistent with RCT effects, with no differences between study design subgroup estimates, supporting the pooling of these results. The majority of studies reported HIV treatment
outcomes at 1 year or less, with the exception of one study, where 2-year viral suppression
showed more moderate treatment outcomes as compared to outcomes at 1 year [33]; it is
therefore difficult to draw conclusions on the long-term outcomes of offering ART initiation
in the community.
Based on data from a limited set of studies, community ART initiation appears to increase
ART uptake and as a result shows better viral suppression and retention in care compared to
facility ART initiation and refill. Future research should explore which community ART initiation and refill models are most effective for specific populations, evaluate strategies outside of
the African context, and report on long-term and implementation outcomes, to facilitate the
incorporation of these strategies into HIV programs.
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